X

Trial Profile

REINA: A Phase I Study of Radiation Enhanced IL 12-Necrosis Attraction in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I

Latest Information Update: 29 Dec 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bintrafusp alfa (Primary) ; PDS 0301 (Primary)
Indications Advanced breast cancer; HER2 negative breast cancer; HER2 positive breast cancer; Male breast cancer
Focus Adverse reactions
Acronyms REINA

Most Recent Events

31 Aug 2022 Status changed from recruiting to withdrawn prior to enrolment on sponsors request.
20 Oct 2021 Planned End Date changed from 15 May 2021 to 15 May 2022.
20 Oct 2021 Planned primary completion date changed from 15 May 2021 to 15 May 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com